ABCB1 and breast cancer: Clinical studies have found similar results: one group compared the expression of ABCB1 to the presence of breast cancer cells in axillary nodes, and found that the group with the transporter expression had an 81.8% chance of being metastatic compared to 54.2% of the group with breast cancer with undetectable ABCB1 expression115.